Synthesis of 2-(5-(2-((5-(Cyclohexylamino)-1,3,4-Thiadiazol-2-yl)thio)ethyl)-1,3,4-Oxadiazol-2-yl) Derivatives and Their Antimicrobial Activity

The rate of invasive fungal infections has increased since the 1980s, particularly in the vast populace of immunocompromised patients as well as those hospitalized with serious underlying disease [1]. [...]

Bibliographic Details
Main Authors: Serkan Levent, Betül Kaya Çavuşoğlu, Yusuf Özkay, Zafer Asım Kaplancıklı
Format: Article
Language:English
Published: MDPI AG 2017-10-01
Series:Proceedings
Subjects:
n/a
Online Access:https://www.mdpi.com/2504-3900/1/6/637
id doaj-98a49872ce364ba5aa6dcbcac65e20a4
record_format Article
spelling doaj-98a49872ce364ba5aa6dcbcac65e20a42020-11-25T01:01:55ZengMDPI AGProceedings2504-39002017-10-011663710.3390/proceedings1060637proceedings1060637Synthesis of 2-(5-(2-((5-(Cyclohexylamino)-1,3,4-Thiadiazol-2-yl)thio)ethyl)-1,3,4-Oxadiazol-2-yl) Derivatives and Their Antimicrobial ActivitySerkan Levent0Betül Kaya Çavuşoğlu1Yusuf Özkay2Zafer Asım Kaplancıklı3Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, TurkeyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, TurkeyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, TurkeyDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, TurkeyThe rate of invasive fungal infections has increased since the 1980s, particularly in the vast populace of immunocompromised patients as well as those hospitalized with serious underlying disease [1]. [...]https://www.mdpi.com/2504-3900/1/6/637n/a
collection DOAJ
language English
format Article
sources DOAJ
author Serkan Levent
Betül Kaya Çavuşoğlu
Yusuf Özkay
Zafer Asım Kaplancıklı
spellingShingle Serkan Levent
Betül Kaya Çavuşoğlu
Yusuf Özkay
Zafer Asım Kaplancıklı
Synthesis of 2-(5-(2-((5-(Cyclohexylamino)-1,3,4-Thiadiazol-2-yl)thio)ethyl)-1,3,4-Oxadiazol-2-yl) Derivatives and Their Antimicrobial Activity
Proceedings
n/a
author_facet Serkan Levent
Betül Kaya Çavuşoğlu
Yusuf Özkay
Zafer Asım Kaplancıklı
author_sort Serkan Levent
title Synthesis of 2-(5-(2-((5-(Cyclohexylamino)-1,3,4-Thiadiazol-2-yl)thio)ethyl)-1,3,4-Oxadiazol-2-yl) Derivatives and Their Antimicrobial Activity
title_short Synthesis of 2-(5-(2-((5-(Cyclohexylamino)-1,3,4-Thiadiazol-2-yl)thio)ethyl)-1,3,4-Oxadiazol-2-yl) Derivatives and Their Antimicrobial Activity
title_full Synthesis of 2-(5-(2-((5-(Cyclohexylamino)-1,3,4-Thiadiazol-2-yl)thio)ethyl)-1,3,4-Oxadiazol-2-yl) Derivatives and Their Antimicrobial Activity
title_fullStr Synthesis of 2-(5-(2-((5-(Cyclohexylamino)-1,3,4-Thiadiazol-2-yl)thio)ethyl)-1,3,4-Oxadiazol-2-yl) Derivatives and Their Antimicrobial Activity
title_full_unstemmed Synthesis of 2-(5-(2-((5-(Cyclohexylamino)-1,3,4-Thiadiazol-2-yl)thio)ethyl)-1,3,4-Oxadiazol-2-yl) Derivatives and Their Antimicrobial Activity
title_sort synthesis of 2-(5-(2-((5-(cyclohexylamino)-1,3,4-thiadiazol-2-yl)thio)ethyl)-1,3,4-oxadiazol-2-yl) derivatives and their antimicrobial activity
publisher MDPI AG
series Proceedings
issn 2504-3900
publishDate 2017-10-01
description The rate of invasive fungal infections has increased since the 1980s, particularly in the vast populace of immunocompromised patients as well as those hospitalized with serious underlying disease [1]. [...]
topic n/a
url https://www.mdpi.com/2504-3900/1/6/637
work_keys_str_mv AT serkanlevent synthesisof2525cyclohexylamino134thiadiazol2ylthioethyl134oxadiazol2ylderivativesandtheirantimicrobialactivity
AT betulkayacavusoglu synthesisof2525cyclohexylamino134thiadiazol2ylthioethyl134oxadiazol2ylderivativesandtheirantimicrobialactivity
AT yusufozkay synthesisof2525cyclohexylamino134thiadiazol2ylthioethyl134oxadiazol2ylderivativesandtheirantimicrobialactivity
AT zaferasımkaplancıklı synthesisof2525cyclohexylamino134thiadiazol2ylthioethyl134oxadiazol2ylderivativesandtheirantimicrobialactivity
_version_ 1725206775287775232